Stericycle (NASDAQ:SRCL) Now Covered by StockNews.com

Research analysts at StockNews.com started coverage on shares of Stericycle (NASDAQ:SRCLGet Free Report) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the business services provider’s stock.

Several other research firms have also weighed in on SRCL. Royal Bank of Canada restated a “sector perform” rating and set a $62.00 target price (down from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. Keefe, Bruyette & Woods raised their target price on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a report on Tuesday, June 4th. Finally, Truist Financial lifted their price objective on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research note on Tuesday, June 4th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat, Stericycle has a consensus rating of “Hold” and an average price target of $74.00.

Read Our Latest Report on SRCL

Stericycle Stock Up 4.6 %

Shares of Stericycle stock opened at $61.60 on Monday. The stock’s fifty day moving average is $58.65 and its 200-day moving average is $54.21. The firm has a market capitalization of $5.72 billion, a PE ratio of -280.00, a price-to-earnings-growth ratio of 3.24 and a beta of 1.11. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle has a 12-month low of $37.78 and a 12-month high of $61.71.

Stericycle (NASDAQ:SRCLGet Free Report) last issued its earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. The company had revenue of $661.60 million during the quarter, compared to analyst estimates of $672.07 million. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. Equities analysts anticipate that Stericycle will post 2.29 earnings per share for the current year.

Hedge Funds Weigh In On Stericycle

A number of large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its holdings in Stericycle by 0.6% during the 4th quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock worth $444,509,000 after purchasing an additional 52,576 shares in the last quarter. Capital Research Global Investors increased its holdings in Stericycle by 11.4% during the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after purchasing an additional 679,974 shares in the last quarter. Earnest Partners LLC boosted its stake in shares of Stericycle by 12.4% during the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock worth $129,766,000 after buying an additional 271,025 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Stericycle by 7.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,171,659 shares of the business services provider’s stock worth $126,238,000 after buying an additional 142,814 shares during the last quarter. Finally, Schroder Investment Management Group boosted its stake in shares of Stericycle by 8.1% during the 4th quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock worth $86,217,000 after buying an additional 129,822 shares during the last quarter. Institutional investors own 98.82% of the company’s stock.

Stericycle Company Profile

(Get Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Recommended Stories

Analyst Recommendations for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.